ID   CERU_HUMAN              Reviewed;        1065 AA.
AC   P00450; Q14063; Q2PP18; Q9UKS4;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   13-AUG-1987, sequence version 1.
DT   22-JUL-2015, entry version 182.
DE   RecName: Full=Ceruloplasmin;
DE            EC=1.16.3.1;
DE   AltName: Full=Ferroxidase;
DE   Flags: Precursor;
GN   Name=CP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2873574; DOI=10.1073/pnas.83.14.5086;
RA   Koschinsky M.L., Funk W.D., van Oost B.A., McGillivray R.T.A.;
RT   "Complete cDNA sequence of human preceruloplasmin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:5086-5090(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (DEC-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-1006.
RX   PubMed=7702601; DOI=10.1006/bbrc.1995.1437;
RA   Daimon M., Yamatani K., Igarashi M., Fukase N., Kawanami T., Kato T.,
RA   Tominaga M., Sasaki H.;
RT   "Fine structure of the human ceruloplasmin gene.";
RL   Biochem. Biophys. Res. Commun. 208:1028-1035(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-40; 549-599; 784-829 AND 919-952.
RX   PubMed=3755405; DOI=10.1016/0014-5793(86)80739-6;
RA   Mercer J.F.B., Grimes A.;
RT   "Isolation of a human ceruloplasmin cDNA clone that includes the N-
RT   terminal leader sequence.";
RL   FEBS Lett. 203:185-190(1986).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-22.
RA   Bingle C.D.;
RT   "Cloning and functional analysis of the human ceruloplasmin gene
RT   minimal promoter.";
RL   Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 218-1065.
RX   PubMed=3486416; DOI=10.1073/pnas.83.10.3257;
RA   Yang F., Naylor S.L., Lum J.B., Cutshaw S., McCombs J.L.,
RA   Naberhaus K.H., McGill J.R., Adrian G.S., Moore C.M., Barnett D.R.,
RA   Bowman B.H.;
RT   "Characterization, mapping, and expression of the human ceruloplasmin
RT   gene.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:3257-3261(1986).
RN   [7]
RP   PROTEIN SEQUENCE OF 20-1065.
RX   PubMed=6582496; DOI=10.1073/pnas.81.2.390;
RA   Takahashi N., Ortel T.L., Putnam F.W.;
RT   "Single-chain structure of human ceruloplasmin: the complete amino
RT   acid sequence of the whole molecule.";
RL   Proc. Natl. Acad. Sci. U.S.A. 81:390-394(1984).
RN   [8]
RP   PROTEIN SEQUENCE OF 158-333; 518-724 AND 858-1065.
RX   PubMed=6571985; DOI=10.1073/pnas.80.1.115;
RA   Takahashi N., Bauman R.A., Ortel T.L., Dwulet F.E., Wang C.-C.,
RA   Putnam F.W.;
RT   "Internal triplication in the structure of human ceruloplasmin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 80:115-119(1983).
RN   [9]
RP   PROTEIN SEQUENCE OF 501-905.
RX   PubMed=6940148; DOI=10.1073/pnas.78.2.790;
RA   Dwulet F.E., Putnam F.W.;
RT   "Complete amino acid sequence of a 50,000-dalton fragment of human
RT   ceruloplasmin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 78:790-794(1981).
RN   [10]
RP   PROTEIN SEQUENCE OF 907-1065.
RX   PubMed=6987229;
RA   Kingston I.B., Kingston B.L., Putnam F.W.;
RT   "Primary structure of a histidine-rich proteolytic fragment of human
RT   ceruloplasmin. I. Amino acid sequence of the cyanogen bromide
RT   peptides.";
RL   J. Biol. Chem. 255:2878-2885(1980).
RN   [11]
RP   PROTEIN SEQUENCE OF 907-1065.
RX   PubMed=6987230;
RA   Kingston I.B., Kingston B.L., Putnam F.W.;
RT   "Primary structure of a histidine-rich proteolytic fragment of human
RT   ceruloplasmin. II. Amino acid sequence of the tryptic peptides.";
RL   J. Biol. Chem. 255:2886-2896(1980).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1007-1061.
RX   PubMed=2355023;
RA   Yang F.M., Friedrichs W.E., Cupples R.L., Banifacio M.J.,
RA   Sanford J.A., Horton W.A., Bowman B.H.;
RT   "Human ceruloplasmin. Tissue-specific expression of transcripts
RT   produced by alternative splicing.";
RL   J. Biol. Chem. 265:10780-10785(1990).
RN   [13]
RP   REVIEW.
RX   PubMed=12055353; DOI=10.1146/annurev.nutr.22.012502.114457;
RA   Hellman N.E., Gitlin J.D.;
RT   "Ceruloplasmin metabolism and function.";
RL   Annu. Rev. Nutr. 22:439-458(2002).
RN   [14]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-138.
RC   TISSUE=Bile;
RX   PubMed=15084671; DOI=10.1074/mcp.M400015-MCP200;
RA   Kristiansen T.Z., Bunkenborg J., Gronborg M., Molina H.,
RA   Thuluvath P.J., Argani P., Goggins M.G., Maitra A., Pandey A.;
RT   "A proteomic analysis of human bile.";
RL   Mol. Cell. Proteomics 3:715-728(2004).
RN   [15]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-138; ASN-397 AND ASN-762.
RC   TISSUE=Plasma;
RX   PubMed=14760718; DOI=10.1002/pmic.200300556;
RA   Bunkenborg J., Pilch B.J., Podtelejnikov A.V., Wisniewski J.R.;
RT   "Screening for N-glycosylated proteins by liquid chromatography mass
RT   spectrometry.";
RL   Proteomics 4:454-465(2004).
RN   [16]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-138; ASN-358; ASN-397;
RP   ASN-588; ASN-762 AND ASN-926.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [17]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-138; ASN-358; ASN-397 AND
RP   ASN-762.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [18]
RP   GLYCOSYLATION AT ASN-138; ASN-358; ASN-397 AND ASN-762.
RX   PubMed=19139490; DOI=10.1074/mcp.M800504-MCP200;
RA   Jia W., Lu Z., Fu Y., Wang H.P., Wang L.H., Chi H., Yuan Z.F.,
RA   Zheng Z.B., Song L.N., Han H.H., Liang Y.M., Wang J.L., Cai Y.,
RA   Zhang Y.K., Deng Y.L., Ying W.T., He S.M., Qian X.H.;
RT   "A strategy for precise and large scale identification of core
RT   fucosylated glycoproteins.";
RL   Mol. Cell. Proteomics 8:913-923(2009).
RN   [19]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-138; ASN-358 AND ASN-397,
RP   AND STRUCTURE OF CARBOHYDRATES.
RC   TISSUE=Cerebrospinal fluid;
RX   PubMed=19838169; DOI=10.1038/nmeth.1392;
RA   Nilsson J., Rueetschi U., Halim A., Hesse C., Carlsohn E.,
RA   Brinkmalm G., Larson G.;
RT   "Enrichment of glycopeptides for glycan structure and attachment site
RT   identification.";
RL   Nat. Methods 6:809-811(2009).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS), DISULFIDE BONDS, AND
RP   METAL-BINDING SITES.
RA   Zaitseva I., Zaitsev V., Card G., Moshkov K., Bax B., Ralph A.,
RA   Lindley P.;
RT   "The X-ray structure of human serum ceruloplasmin at 3.1 A: nature of
RT   the copper centres.";
RL   J. Biol. Inorg. Chem. 1:15-23(1996).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS), METAL-BINDING SITES, AND
RP   DISULFIDE BONDS.
RX   PubMed=17242517; DOI=10.1107/S090744490604947X;
RA   Bento I., Peixoto C., Zaitsev V.N., Lindley P.F.;
RT   "Ceruloplasmin revisited: structural and functional roles of various
RT   metal cation-binding sites.";
RL   Acta Crystallogr. D 63:240-248(2007).
RN   [23]
RP   VARIANTS THR-63; LEU-477; GLU-544; ILE-551; HIS-793 AND ARG-841.
RX   PubMed=15557511; DOI=10.1212/01.WNL.0000144276.29988.C3;
RA   Hochstrasser H., Bauer P., Walter U., Behnke S., Spiegel J., Csoti I.,
RA   Zeiler B., Bornemann A., Pahnke J., Becker G., Riess O., Berg D.;
RT   "Ceruloplasmin gene variations and substantia nigra hyperechogenicity
RT   in Parkinson disease.";
RL   Neurology 63:1912-1917(2004).
RN   [24]
RP   CHARACTERIZATION OF VARIANTS THR-63; GLU-544 AND HIS-793.
RX   PubMed=16150804; DOI=10.1096/fj.04-3486fje;
RA   Hochstrasser H., Tomiuk J., Walter U., Behnke S., Spiegel J.,
RA   Krueger R., Becker G., Riess O., Berg D.;
RT   "Functional relevance of ceruloplasmin mutations in Parkinson's
RT   disease.";
RL   FASEB J. 19:1851-1853(2005).
CC   -!- FUNCTION: Ceruloplasmin is a blue, copper-binding (6-7 atoms per
CC       molecule) glycoprotein. It has ferroxidase activity oxidizing
CC       Fe(2+) to Fe(3+) without releasing radical oxygen species. It is
CC       involved in iron transport across the cell membrane. Provides
CC       Cu(2+) ions for the ascorbate-mediated deaminase degradation of
CC       the heparan sulfate chains of GPC1. May also play a role in fetal
CC       lung development or pulmonary antioxidant defense (By similarity).
CC       {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: 4 Fe(2+) + 4 H(+) + O(2) = 4 Fe(3+) + 2 H(2)O.
CC   -!- COFACTOR:
CC       Name=Cu cation; Xref=ChEBI:CHEBI:23378;
CC       Note=Binds 6 Cu cations per monomer.;
CC   -!- SUBCELLULAR LOCATION: Secreted. Note=Colocalizes with GCP1 in
CC       secretory intracellular compartments. {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed by the liver and secreted in plasma.
CC   -!- DISEASE: Aceruloplasminemia (ACERULOP) [MIM:604290]: An autosomal
CC       recessive disorder of iron metabolism characterized by iron
CC       accumulation in the brain as well as visceral organs. Clinical
CC       features consist of the triad of retinal degeneration, diabetes
CC       mellitus and neurological disturbances. Note=The disease is caused
CC       by mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Note=Ceruloplasmin levels are decreased in Wilson
CC       disease, in which copper cannot be incorporated into ceruloplasmin
CC       in liver because of defects in the copper-transporting ATPase 2.
CC   -!- SIMILARITY: Belongs to the multicopper oxidase family.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Contains 3 F5/8 type A domains. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 6 plastocyanin-like domains. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Ceruloplasmin entry;
CC       URL="http://en.wikipedia.org/wiki/Ceruloplasmin";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M13699; AAA51976.1; -; mRNA.
DR   EMBL; DQ314867; ABC40726.1; -; Genomic_DNA.
DR   EMBL; D45045; BAA08085.1; -; Genomic_DNA.
DR   EMBL; D00025; BAA00019.1; -; mRNA.
DR   EMBL; X04135; CAA27752.1; -; mRNA.
DR   EMBL; X04136; CAA27753.1; -; mRNA.
DR   EMBL; X04137; CAA27754.1; -; mRNA.
DR   EMBL; X04138; CAA27755.1; -; mRNA.
DR   EMBL; AF132978; AAF02483.1; -; Genomic_DNA.
DR   EMBL; M13536; AAA51975.1; -; mRNA.
DR   EMBL; J05506; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS3141.1; -.
DR   PIR; A25443; KUHU.
DR   RefSeq; NP_000087.1; NM_000096.3.
DR   UniGene; Hs.558314; -.
DR   PDB; 1KCW; X-ray; 3.00 A; A=20-1065.
DR   PDB; 2J5W; X-ray; 2.80 A; A=1-1065.
DR   PDB; 4EJX; X-ray; 4.69 A; A=1-1065.
DR   PDB; 4ENZ; X-ray; 2.60 A; A=1-1065.
DR   PDBsum; 1KCW; -.
DR   PDBsum; 2J5W; -.
DR   PDBsum; 4EJX; -.
DR   PDBsum; 4ENZ; -.
DR   ProteinModelPortal; P00450; -.
DR   BioGrid; 107748; 6.
DR   IntAct; P00450; 5.
DR   STRING; 9606.ENSP00000264613; -.
DR   DrugBank; DB00055; Drotrecogin alfa.
DR   PhosphoSite; P00450; -.
DR   UniCarbKB; P00450; -.
DR   BioMuta; CP; -.
DR   DMDM; 116117; -.
DR   DOSAC-COBS-2DPAGE; P00450; -.
DR   SWISS-2DPAGE; P00450; -.
DR   MaxQB; P00450; -.
DR   PaxDb; P00450; -.
DR   PeptideAtlas; P00450; -.
DR   PRIDE; P00450; -.
DR   Ensembl; ENST00000264613; ENSP00000264613; ENSG00000047457.
DR   GeneID; 1356; -.
DR   KEGG; hsa:1356; -.
DR   UCSC; uc003ewy.4; human.
DR   CTD; 1356; -.
DR   GeneCards; GC03M148880; -.
DR   GeneReviews; CP; -.
DR   HGNC; HGNC:2295; CP.
DR   HPA; CAB008591; -.
DR   HPA; HPA001834; -.
DR   MIM; 117700; gene.
DR   MIM; 604290; phenotype.
DR   neXtProt; NX_P00450; -.
DR   Orphanet; 48818; Aceruloplasminemia.
DR   PharmGKB; PA26815; -.
DR   eggNOG; NOG276067; -.
DR   HOGENOM; HOG000231499; -.
DR   HOVERGEN; HBG003674; -.
DR   InParanoid; P00450; -.
DR   KO; K13624; -.
DR   PhylomeDB; P00450; -.
DR   TreeFam; TF329807; -.
DR   BioCyc; MetaCyc:HS00590-MONOMER; -.
DR   BRENDA; 1.16.3.1; 2681.
DR   Reactome; REACT_20547; Metal ion SLC transporters.
DR   Reactome; REACT_25060; Iron uptake and transport.
DR   SABIO-RK; P00450; -.
DR   ChiTaRS; CP; human.
DR   EvolutionaryTrace; P00450; -.
DR   GeneWiki; Ceruloplasmin; -.
DR   GenomeRNAi; 1356; -.
DR   NextBio; 5493; -.
DR   PMAP-CutDB; P00450; -.
DR   PRO; PR:P00450; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; P00450; -.
DR   CleanEx; HS_CP; -.
DR   ExpressionAtlas; P00450; baseline and differential.
DR   Genevisible; P00450; HS.
DR   GO; GO:0072562; C:blood microparticle; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; NAS:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0005765; C:lysosomal membrane; IDA:UniProtKB.
DR   GO; GO:0051087; F:chaperone binding; IPI:BHF-UCL.
DR   GO; GO:0005507; F:copper ion binding; IEA:Ensembl.
DR   GO; GO:0004322; F:ferroxidase activity; TAS:Reactome.
DR   GO; GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome.
DR   GO; GO:0006825; P:copper ion transport; IEA:UniProtKB-KW.
DR   GO; GO:0055085; P:transmembrane transport; TAS:Reactome.
DR   Gene3D; 2.60.40.420; -; 6.
DR   InterPro; IPR027150; CP.
DR   InterPro; IPR001117; Cu-oxidase.
DR   InterPro; IPR011706; Cu-oxidase_2.
DR   InterPro; IPR011707; Cu-oxidase_3.
DR   InterPro; IPR002355; Cu_oxidase_Cu_BS.
DR   InterPro; IPR008972; Cupredoxin.
DR   PANTHER; PTHR10127:SF294; PTHR10127:SF294; 1.
DR   Pfam; PF00394; Cu-oxidase; 1.
DR   Pfam; PF07731; Cu-oxidase_2; 1.
DR   Pfam; PF07732; Cu-oxidase_3; 2.
DR   SUPFAM; SSF49503; SSF49503; 6.
DR   PROSITE; PS00079; MULTICOPPER_OXIDASE1; 3.
DR   PROSITE; PS00080; MULTICOPPER_OXIDASE2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Copper; Copper transport;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein;
KW   Ion transport; Metal-binding; Oxidoreductase; Polymorphism;
KW   Reference proteome; Repeat; Secreted; Signal; Transport.
FT   SIGNAL        1     19       {ECO:0000269|PubMed:6582496}.
FT   CHAIN        20   1065       Ceruloplasmin.
FT                                /FTId=PRO_0000002912.
FT   DOMAIN       20    357       F5/8 type A 1.
FT   DOMAIN       20    200       Plastocyanin-like 1.
FT   DOMAIN      209    357       Plastocyanin-like 2.
FT   DOMAIN      370    718       F5/8 type A 2.
FT   DOMAIN      370    560       Plastocyanin-like 3.
FT   DOMAIN      570    718       Plastocyanin-like 4.
FT   DOMAIN      730   1061       F5/8 type A 3.
FT   DOMAIN      730    900       Plastocyanin-like 5.
FT   DOMAIN      908   1061       Plastocyanin-like 6.
FT   METAL       120    120       Copper 1; type 2.
FT   METAL       122    122       Copper 2; type 3.
FT   METAL       180    180       Copper 2; type 3.
FT   METAL       182    182       Copper 3; type 3.
FT   METAL       295    295       Copper 4; type 1.
FT   METAL       338    338       Copper 4; type 1.
FT   METAL       343    343       Copper 4; type 1.
FT   METAL       656    656       Copper 5; type 1.
FT   METAL       699    699       Copper 5; type 1.
FT   METAL       704    704       Copper 5; type 1.
FT   METAL       709    709       Copper 5; type 1.
FT   METAL       994    994       Copper 6; type 1.
FT   METAL       997    997       Copper 1; type 2.
FT   METAL       999    999       Copper 3; type 3.
FT   METAL      1039   1039       Copper 3; type 3.
FT   METAL      1040   1040       Copper 6; type 1.
FT   METAL      1041   1041       Copper 2; type 3.
FT   METAL      1045   1045       Copper 6; type 1.
FT   METAL      1050   1050       Copper 6; type 1.
FT   CARBOHYD    138    138       N-linked (GlcNAc...) (complex).
FT                                {ECO:0000269|PubMed:14760718,
FT                                ECO:0000269|PubMed:15084671,
FT                                ECO:0000269|PubMed:16335952,
FT                                ECO:0000269|PubMed:19139490,
FT                                ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:19838169}.
FT   CARBOHYD    358    358       N-linked (GlcNAc...) (complex).
FT                                {ECO:0000269|PubMed:16335952,
FT                                ECO:0000269|PubMed:19139490,
FT                                ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:19838169}.
FT   CARBOHYD    397    397       N-linked (GlcNAc...) (complex).
FT                                {ECO:0000269|PubMed:14760718,
FT                                ECO:0000269|PubMed:16335952,
FT                                ECO:0000269|PubMed:19139490,
FT                                ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:19838169}.
FT   CARBOHYD    588    588       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:16335952}.
FT   CARBOHYD    762    762       N-linked (GlcNAc...) (complex).
FT                                {ECO:0000269|PubMed:14760718,
FT                                ECO:0000269|PubMed:16335952,
FT                                ECO:0000269|PubMed:19139490,
FT                                ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    926    926       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:16335952}.
FT   DISULFID    174    200       {ECO:0000305}.
FT   DISULFID    276    357       {ECO:0000305}.
FT   DISULFID    534    560       {ECO:0000305}.
FT   DISULFID    637    718       {ECO:0000305}.
FT   DISULFID    874    900       {ECO:0000305}.
FT   VARIANT      63     63       I -> T (retained in the ER due to
FT                                impaired N-glycosylation; may present a
FT                                vulnerability factor for iron induced
FT                                oxidative stress in Parkinson disease).
FT                                {ECO:0000269|PubMed:15557511,
FT                                ECO:0000269|PubMed:16150804}.
FT                                /FTId=VAR_025655.
FT   VARIANT     367    367       R -> C (in dbSNP:rs34624984).
FT                                /FTId=VAR_032815.
FT   VARIANT     477    477       P -> L (in dbSNP:rs35331711).
FT                                {ECO:0000269|PubMed:15557511}.
FT                                /FTId=VAR_025656.
FT   VARIANT     544    544       D -> E (reduced ferroxidase activity; may
FT                                present a vulnerability factor for iron
FT                                induced oxidative stress in Parkinson
FT                                disease; dbSNP:rs701753).
FT                                {ECO:0000269|PubMed:15557511,
FT                                ECO:0000269|PubMed:16150804}.
FT                                /FTId=VAR_025657.
FT   VARIANT     551    551       T -> I. {ECO:0000269|PubMed:15557511}.
FT                                /FTId=VAR_025658.
FT   VARIANT     793    793       R -> H. {ECO:0000269|PubMed:15557511,
FT                                ECO:0000269|PubMed:16150804}.
FT                                /FTId=VAR_025659.
FT   VARIANT     841    841       T -> R (in dbSNP:rs56033670).
FT                                {ECO:0000269|PubMed:15557511}.
FT                                /FTId=VAR_025660.
FT   CONFLICT   1060   1060       E -> EGEYP (in Ref. 6; AAA51975).
FT                                {ECO:0000305}.
FT   STRAND       21     36       {ECO:0000244|PDB:4ENZ}.
FT   TURN         49     52       {ECO:0000244|PDB:4ENZ}.
FT   HELIX        53     56       {ECO:0000244|PDB:4ENZ}.
FT   STRAND       58     61       {ECO:0000244|PDB:1KCW}.
FT   STRAND       65     79       {ECO:0000244|PDB:4ENZ}.
FT   STRAND       82     84       {ECO:0000244|PDB:1KCW}.
FT   HELIX        88     90       {ECO:0000244|PDB:4ENZ}.
FT   STRAND       97    100       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      104    111       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      113    115       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      120    125       {ECO:0000244|PDB:4ENZ}.
FT   HELIX       128    130       {ECO:0000244|PDB:4ENZ}.
FT   HELIX       141    144       {ECO:0000244|PDB:4ENZ}.
FT   HELIX       145    147       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      154    160       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      173    180       {ECO:0000244|PDB:4ENZ}.
FT   HELIX       185    190       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      194    200       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      205    210       {ECO:0000244|PDB:2J5W}.
FT   STRAND      214    225       {ECO:0000244|PDB:4ENZ}.
FT   HELIX       226    228       {ECO:0000244|PDB:4ENZ}.
FT   HELIX       232    239       {ECO:0000244|PDB:4ENZ}.
FT   HELIX       243    245       {ECO:0000244|PDB:4ENZ}.
FT   HELIX       251    257       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      258    262       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      274    276       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      280    287       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      295    301       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      304    306       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      309    312       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      321    327       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      332    338       {ECO:0000244|PDB:4ENZ}.
FT   HELIX       341    344       {ECO:0000244|PDB:4ENZ}.
FT   TURN        345    347       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      349    355       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      367    385       {ECO:0000244|PDB:4ENZ}.
FT   TURN        392    394       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      401    403       {ECO:0000244|PDB:1KCW}.
FT   HELIX       406    409       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      412    414       {ECO:0000244|PDB:1KCW}.
FT   STRAND      418    427       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      429    435       {ECO:0000244|PDB:4ENZ}.
FT   HELIX       444    446       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      453    456       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      459    471       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      476    481       {ECO:0000244|PDB:4ENZ}.
FT   HELIX       484    486       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      514    520       {ECO:0000244|PDB:4ENZ}.
FT   TURN        523    525       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      529    531       {ECO:0000244|PDB:2J5W}.
FT   STRAND      533    540       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      542    544       {ECO:0000244|PDB:2J5W}.
FT   HELIX       545    551       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      554    560       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      575    580       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      582    586       {ECO:0000244|PDB:4ENZ}.
FT   HELIX       587    589       {ECO:0000244|PDB:4ENZ}.
FT   HELIX       593    600       {ECO:0000244|PDB:4ENZ}.
FT   HELIX       604    606       {ECO:0000244|PDB:4ENZ}.
FT   HELIX       612    617       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      619    623       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      635    637       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      642    647       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      656    660       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      665    667       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      670    677       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      682    687       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      693    699       {ECO:0000244|PDB:4ENZ}.
FT   HELIX       702    706       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      710    716       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      729    745       {ECO:0000244|PDB:4ENZ}.
FT   HELIX       750    759       {ECO:0000244|PDB:4ENZ}.
FT   TURN        766    768       {ECO:0000244|PDB:4ENZ}.
FT   TURN        771    773       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      777    789       {ECO:0000244|PDB:4ENZ}.
FT   HELIX       800    805       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      812    815       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      818    826       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      828    830       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      835    838       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      842    844       {ECO:0000244|PDB:1KCW}.
FT   STRAND      854    860       {ECO:0000244|PDB:4ENZ}.
FT   HELIX       863    865       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      869    871       {ECO:0000244|PDB:1KCW}.
FT   STRAND      873    880       {ECO:0000244|PDB:4ENZ}.
FT   HELIX       885    890       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      894    900       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      913    924       {ECO:0000244|PDB:4ENZ}.
FT   HELIX       925    927       {ECO:0000244|PDB:4ENZ}.
FT   HELIX       931    938       {ECO:0000244|PDB:4ENZ}.
FT   HELIX       942    944       {ECO:0000244|PDB:4ENZ}.
FT   HELIX       950    955       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      957    961       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      973    975       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      979    986       {ECO:0000244|PDB:4ENZ}.
FT   STRAND      994    998       {ECO:0000244|PDB:4ENZ}.
FT   STRAND     1003   1006       {ECO:0000244|PDB:4ENZ}.
FT   HELIX      1007   1009       {ECO:0000244|PDB:4ENZ}.
FT   STRAND     1011   1018       {ECO:0000244|PDB:4ENZ}.
FT   STRAND     1023   1028       {ECO:0000244|PDB:4ENZ}.
FT   STRAND     1034   1040       {ECO:0000244|PDB:4ENZ}.
FT   HELIX      1043   1047       {ECO:0000244|PDB:4ENZ}.
FT   STRAND     1051   1057       {ECO:0000244|PDB:4ENZ}.
SQ   SEQUENCE   1065 AA;  122205 MW;  2F2F1294E2D30F58 CRC64;
     MKILILGIFL FLCSTPAWAK EKHYYIGIIE TTWDYASDHG EKKLISVDTE HSNIYLQNGP
     DRIGRLYKKA LYLQYTDETF RTTIEKPVWL GFLGPIIKAE TGDKVYVHLK NLASRPYTFH
     SHGITYYKEH EGAIYPDNTT DFQRADDKVY PGEQYTYMLL ATEEQSPGEG DGNCVTRIYH
     SHIDAPKDIA SGLIGPLIIC KKDSLDKEKE KHIDREFVVM FSVVDENFSW YLEDNIKTYC
     SEPEKVDKDN EDFQESNRMY SVNGYTFGSL PGLSMCAEDR VKWYLFGMGN EVDVHAAFFH
     GQALTNKNYR IDTINLFPAT LFDAYMVAQN PGEWMLSCQN LNHLKAGLQA FFQVQECNKS
     SSKDNIRGKH VRHYYIAAEE IIWNYAPSGI DIFTKENLTA PGSDSAVFFE QGTTRIGGSY
     KKLVYREYTD ASFTNRKERG PEEEHLGILG PVIWAEVGDT IRVTFHNKGA YPLSIEPIGV
     RFNKNNEGTY YSPNYNPQSR SVPPSASHVA PTETFTYEWT VPKEVGPTNA DPVCLAKMYY
     SAVDPTKDIF TGLIGPMKIC KKGSLHANGR QKDVDKEFYL FPTVFDENES LLLEDNIRMF
     TTAPDQVDKE DEDFQESNKM HSMNGFMYGN QPGLTMCKGD SVVWYLFSAG NEADVHGIYF
     SGNTYLWRGE RRDTANLFPQ TSLTLHMWPD TEGTFNVECL TTDHYTGGMK QKYTVNQCRR
     QSEDSTFYLG ERTYYIAAVE VEWDYSPQRE WEKELHHLQE QNVSNAFLDK GEFYIGSKYK
     KVVYRQYTDS TFRVPVERKA EEEHLGILGP QLHADVGDKV KIIFKNMATR PYSIHAHGVQ
     TESSTVTPTL PGETLTYVWK IPERSGAGTE DSACIPWAYY STVDQVKDLY SGLIGPLIVC
     RRPYLKVFNP RRKLEFALLF LVFDENESWY LDDNIKTYSD HPEKVNKDDE EFIESNKMHA
     INGRMFGNLQ GLTMHVGDEV NWYLMGMGNE IDLHTVHFHG HSFQYKHRGV YSSDVFDIFP
     GTYQTLEMFP RTPGIWLLHC HVTDHIHAGM ETTYTVLQNE DTKSG
//
